UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------
SCHEDULE 13D
Under the Securities Exchange Act of 1934
BIO-LIFE LABS, INC.
(Name of Issuer)
Common Stock, $0.0001 par value
(Title of Class of Securities)
09059S-10-9
(CUSIP Number)
Global Asset Management, LLC
488 Madison Avenue
New York, NY 10022
(212) 209-3090
(Name, Address and Telephone Number of
Person Authorized to Receive Notices and Communications)
May 19, 2005
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check
the following box |_|.
Note. Schedules filed in paper format shall include a signed original and
five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 (the "Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
CUSIP No. 09059S-10-9
--------------------------------------------------------------------------------
1) Name of Reporting Person - I.R.S. Identification No. of person
(entities only).
Global Asset Management LLC (I.R.S. Identification No. 20-026-3612)
--------------------------------------------------------------------------------
2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a) |_|
(b) |X|
--------------------------------------------------------------------------------
3) SEC Use Only
--------------------------------------------------------------------------------
4) Source of Funds (See Instructions)
OO
--------------------------------------------------------------------------------
5) Check if Disclosure of Legal Proceedings Is Required Pursuant to
Items 2(d) or 2(e) ................................................... |_|
--------------------------------------------------------------------------------
6) Citizenship or Place of Organization
Delaware
--------------------------------------------------------------------------------
7) Sole Voting Power
3,849,999
NUMBER ---------------------------------------------------------------
OF SHARES 8) Shared Voting Power
BENEFICIALLY
OWNED BY 0
EACH ---------------------------------------------------------------
REPORTING 9) Sole Dispositive Power
PERSON WITH
3,849,999
---------------------------------------------------------------
10) Shared Dispositive Power
0
--------------------------------------------------------------------------------
11) Aggregate Amount Beneficially Owned by Each Reporting Person
3,849,999
--------------------------------------------------------------------------------
12) Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions)
|_|
--------------------------------------------------------------------------------
13) Percent of Class Represented by Amount in Row (11)
6%
--------------------------------------------------------------------------------
14) Type of Reporting Person (See Instructions)
CO
--------------------------------------------------------------------------------
Item 1. Security and Issuer.
This statement (this "Statement") relates to the common stock, par value
$0.0001 per share ("Common Stock") of BIO-LIFE LABS, INC., a Nevada corporation
(the "Issuer"). The principal executive offices of the Issuer are located at
9911 West Pico Boulevard, Suite 1410, Los Angeles, California 90035.
Item 2. Identity and Background.
(a) This Statement is being filed by Global Asset Management, LLC
("Global"), a limited liability corporation, by its President and
sole member, Robert Fallah.
(b) The business address of Global is 488 Madison Avenue, Suite 802, New
York, New York 10022.
(c) Global is an investment fund.
(d)-(e) No executive officer or director of Global nor any controlling
shareholder of Global, during the last five years, has been
convicted in a criminal proceeding (excluding traffic violations or
similar misdemeanors), or been a party to a civil proceeding of a
judicial or administrative body of competent jurisdiction resulting
in a judgment, decree or final order enjoining future violations of,
or prohibiting or mandating activities subject to, Federal or state
securities laws or finding any violation with respect to such laws.
(f) The state of organization of Global is Delaware and Mr. Fallah is a
United States Citizen.
Item 3. Source and Amount of Funds or Other Consideration.
The source of funds paid for 3,899,999 shares of Common Stock of the
Issuer owned by Global were personal funds of Mr. Fallah.
Item 4. Purpose of Transaction.
The 3,899,999 shares of Common Stock of the Issuer were purchased by
Global for investment purposes.
Except as otherwise described herein, neither Global, nor any of its
executive officers, directors or controlling shareholders, have any plans or
proposals as of the date hereof which relate to or would result in (a) the
acquisition by any person of additional securities of the Issuer or the
disposition of any such securities, (b) an extraordinary corporate transaction,
such as a merger, reorganization or liquidation, involving the Issuer or any of
its subsidiaries, (c) a sale or transfer of a material amount of assets of the
Issuer or any of its subsidiaries, (d) any change in the present board of
directors or management of the Issuer, (e) any material change in the present
capitalization or dividend policy of the Issuer, (f) any other material change
in the Issuer's business or corporate structure, (g) any change in the Issuer's
charter or By-laws or other actions which may impede the acquisition of control
of the Issuer by any person, (h) causing a class of securities of the Issuer to
be delisted from any national securities exchange or to cease to be authorized
to be quoted on an inter-dealer quotation system of a registered national
securities association, (i) causing a class of equity securities of the Issuer
to be eligible for termination of registration pursuant to Section 12(g)(4) of
the Exchange Act, or (j) any action similar to those enumerated in (a) through
(i) above.
Item 5. Interest in Securities of the Issuer.
(a) At the date of this Statement, Global beneficially owns 3,899,999
shares of Common Stock of the Issuer. This represents approximately 6% of the
61,791,805 total number of the issued and outstanding shares of Common Stock of
the Issuer as of May 19, 2005.
(b) Global has sole dispositive and voting power with respect to 3,899,999
shares of Common Stock of the Issuer.
(c) Other than the Offering, no other transactions in the Common Stock
were effected by Global in the past 60 days.
(d) Not Applicable.
(e) Not Applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to
Securities of the Issuer.
There are no contracts, arrangements, understandings or relationships
(legal or otherwise) between Global and any other person or entity with respect
to any securities of the Issuer, including, but not limited to, transfer or
voting of any of the securities, finder's fees, joint ventures, loan or option
arrangements, puts or calls, guarantees of profits, division of profits or loss,
or the giving or withholding of proxies.
Item 7. Materials to be Filed as Exhibits.
None.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this Statement is true, complete and
correct.
Dated: May 19, 2005
GLOBAL ASSET MANAGEMENT LLC
By: /s/ Robert Fallah
----------------------------------
Robert Fallah, Member